These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38297970)

  • 1. The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.
    Xiong YQ; Li Y; Goncheva MI; Elsayed AM; Zhu F; Li L; Abdelhady W; Flannagan RS; Yeaman MR; Bayer AS; Heinrichs DE
    J Infect Dis; 2024 Jun; 229(6):1648-1657. PubMed ID: 38297970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Mechanistic Insights into Purine Biosynthesis with Second Messenger c-di-AMP in Relation to Biofilm-Related Persistent Methicillin-Resistant Staphylococcus aureus Infections.
    Li L; Li Y; Zhu F; Cheung AL; Wang G; Bai G; Proctor RA; Yeaman MR; Bayer AS; Xiong YQ
    mBio; 2021 Dec; 12(6):e0208121. PubMed ID: 34724823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The purine biosynthesis regulator PurR moonlights as a virulence regulator in
    Sause WE; Balasubramanian D; Irnov I; Copin R; Sullivan MJ; Sommerfield A; Chan R; Dhabaria A; Askenazi M; Ueberheide B; Shopsin B; van Bakel H; Torres VJ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13563-13572. PubMed ID: 31217288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Seidl K; Chen L; Bayer AS; Hady WA; Kreiswirth BN; Xiong YQ
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5631-9. PubMed ID: 21968365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Abdelhady W; Bayer AS; Seidl K; Nast CC; Kiedrowski MR; Horswill AR; Yeaman MR; Xiong YQ
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1447-54. PubMed ID: 23295925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gp05, a Prophage-Encoded Virulence Factor, Contributes to Persistent Methicillin-Resistant Staphylococcus aureus Endovascular Infection.
    Li Y; Zhu F; Manna AC; Chen L; Jiang J; Hong JI; Proctor RA; Bayer AS; Cheung AL; Xiong YQ
    Microbiol Spectr; 2023 Aug; 11(4):e0060023. PubMed ID: 37358448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vancomycin on sarA-mediated biofilm formation: role in persistent endovascular infections due to methicillin-resistant Staphylococcus aureus.
    Abdelhady W; Bayer AS; Seidl K; Moormeier DE; Bayles KW; Cheung A; Yeaman MR; Xiong YQ
    J Infect Dis; 2014 Apr; 209(8):1231-40. PubMed ID: 24403556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Increased Accumulation of Staphylococcus aureus Virulence Factors Is Maximized in a
    Alkam D; Jenjaroenpun P; Ramirez AM; Beenken KE; Spencer HJ; Smeltzer MS
    Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33468580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
    del Río A; García-de-la-Mària C; Entenza JM; Gasch O; Armero Y; Soy D; Mestres CA; Pericás JM; Falces C; Ninot S; Almela M; Cervera C; Gatell JM; Moreno A; Moreillon P; Marco F; Miró JM;
    Antimicrob Agents Chemother; 2016 Jan; 60(1):478-86. PubMed ID: 26525803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics.
    Trotonda MP; Xiong YQ; Memmi G; Bayer AS; Cheung AL
    J Infect Dis; 2009 Jan; 199(2):209-18. PubMed ID: 19072553
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Goncheva MI; Flannagan RS; Heinrichs DE
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32094249
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of relationship between purine biosynthesis and vancomycin resistance in Staphylococcus aureus: a cautionary tale for microarray interpretation.
    Fox PM; Climo MW; Archer GL
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1274-80. PubMed ID: 17242154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
    Fernandez J; Abbanat D; Shang W; He W; Amsler K; Hastings J; Queenan AM; Melton JL; Barron AM; Flamm RK; Lynch AS
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1476-84. PubMed ID: 22232278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model.
    Xiong YQ; Fowler VG; Yeaman MR; Perdreau-Remington F; Kreiswirth BN; Bayer AS
    J Infect Dis; 2009 Jan; 199(2):201-8. PubMed ID: 19086913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina.
    Sola C; Lamberghini RO; Ciarlantini M; Egea AL; Gonzalez P; Diaz EG; Huerta V; Gonzalez J; Corso A; Vilaro M; Petiti JP; Torres A; Vindel A; Bocco JL
    Ann Clin Microbiol Antimicrob; 2011 Apr; 10():15. PubMed ID: 21527033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Purine Biosynthesis in Persistent Methicillin-Resistant Staphylococcus aureus Infection.
    Li L; Abdelhady W; Donegan NP; Seidl K; Cheung A; Zhou YF; Yeaman MR; Bayer AS; Xiong YQ
    J Infect Dis; 2018 Sep; 218(9):1367-1377. PubMed ID: 29868791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Werth BJ; Barber KE; Ireland CE; Rybak MJ
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3177-81. PubMed ID: 24663016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early agr activation correlates with vancomycin treatment failure in multi-clonotype MRSA endovascular infections.
    Abdelhady W; Chen L; Bayer AS; Seidl K; Yeaman MR; Kreiswirth BN; Xiong YQ
    J Antimicrob Chemother; 2015 May; 70(5):1443-52. PubMed ID: 25564565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Seidl K; Bayer AS; McKinnell JA; Ellison S; Filler SG; Xiong YQ
    Cell Microbiol; 2011 Oct; 13(10):1530-41. PubMed ID: 21777408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Stringent Response Contributes to Persistent Methicillin-Resistant Staphylococcus aureus Endovascular Infection Through the Purine Biosynthetic Pathway.
    Li L; Bayer AS; Cheung A; Lu L; Abdelhady W; Donegan NP; Hong JI; Yeaman MR; Xiong YQ
    J Infect Dis; 2020 Sep; 222(7):1188-1198. PubMed ID: 32333768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.